Medical Writing Preclinical Studies Creation of a patient-centric patient lay summary in the local language

Volume 26, Issue 4 - Preclinical Studies

Creation of a patient-centric patient lay summary in the local language


Prior to this project, no patient lay summary (PLS) had ever been developed locally in Japan. In order to create a PLS that is more tailored to local patients, we attempted to develop one in and for Japanese. Such PLS was drafted based on the disclosed summary of the clinical study report. We took a composite approach in refining the PLS by researching on lay language and patient-friendly designs. At the same time, we ensured scientific accuracy through consultation with experts such as physicians and statisticians, practised diligence on regulatory and legal aspects, and incorporated patient’s voice by consulting a local patient advocacy group. We successfully created a PLS in the Japanese language for the first time, which was more patient centric than those translated from another language.
Download the full article


  1. Clinical TrialsRegistry and Results Posting Database. 2017 [cited 2016 September 1]. Available from:
  2. European Medicines Agency. European Clinical Trials Database (EudraCT) V10. 2017 [cited 2016 August 10]. Available from: index.html
  3. Official Journal of the European Union. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on Clinical Trials on Medicinal Products for Human Use, and Repealing Directive 2001/20/EC. 2014 [cited 2016 August 5]. Available from: http://ec.europa. eu/health/files/eudralex/vol-1/reg_2014_ 536/reg_2014_536_ en.pdf
  4. Suga O, Take Y, Ishiguro T, Izuchi M, Udo K, Shibata A, et al. Communicating trial results to study volunteers in Japan [in Japanese]. Regulatory Science of Medical Products. 2016;6 Suppl:54. Available from: http://
  5. Takahashi Y, Katayama N. Design to comunicate: universal design for research presentation. 2012 [cited 2016 September 1] Available from: http://tsutawarudesign.
  6. Pfizer Inc. Clinical study report synopses [cited 2016 September 1] Available from: clinical_trials/trial_results
  7. Pfizer Japan Inc. Patient lay summary [cited 2016 December 1] Available from: patient_lay/index2.html



Preclinical studies
President’s Message
EMWA celebrates 25 years
Preclinical research in drug development
An introduction to little-known aspects of nonclinical regulatory writing
Reporting of preclinical research: What do we get told – when and how?
Mind the gap – towards complete and transparent reporting of animal research
The reproducibility crisis in preclinical research – lessons to learn from clinical research
Nonclinical studies in the Russian Federation — Problems, regulatory norms, and harmonisation with international standards
How to survive Brexit as an independent medical writer
Creation of a patient-centric patient lay summary in the local language
Six communication rules for scientific presentations and writing
So, you want to be a medical journalist?
News from the EMA
Profile: An interview with Steven Walker
Getting Your Foot in the Door
In the Bookstores
Journal Watch
The Webscout
Good Writing Practice
Medical Communications
Out on Our Own

Member Login


The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board



Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: